Homoeopathic treatment of gum bleeding, and swelling in adults

A double-blind, randomized, placebo-controlled trial of individualized homoeopathic medicines in the treatment of gingivitis in adults - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/08/093903

Enrollment

114

Registered

2025-08-29

Start date

Unknown

Completion date

Unknown

Last updated

2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: Individualized homoeopathic medicines in centesimal potencies plus concomitant care: Intervention is planned as administering indicated homoeopathic medicines in centesimal potencies (c

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within

dosage and repetition will be decided depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. All the enrolle

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age between 18 and 65 years 2. Patients suffering from Gingivitis (ICD-11: DA0B). 3. Patients of either sex or transgender. 4. Literate patients; ability to read English and/or Bengali. 5. Providing written informed consent.

Exclusion criteria

Exclusion criteria: 1. Not providing with written informed consent of participation. 2. Patients who are too sick for consultation, unable to read patient information sheet, unwilling to take part or not giving consent to join the study. 3. Vulnerable population- Unconscious, ambulatory, too sick for consultation, differently abled, terminally ill or critically ill patients, institutionalized subjects, and mentally incompetent people. 4. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life or any organ failure 5. Pregnant and puerperal women, lactating mothers 6. Patient under tobacco chewing and/or smoking, betel leaf and/or alcoholism and/or any other form(s) of substance abuse and/or dependence 7. Self-reported immune-compromised state 8. Already undergoing homoeopathic treatment for chronic disease within last 6 months.

Design outcomes

Primary

Measure	Time frame
Bleeding On Marginal Probing (BOMP) indexTimepoint: At baseline, after 1 month and 2 months of intervention	—

Secondary

Measure	Time frame
Gingival Index (GI) scoreTimepoint: At baseline, after 1 month and 2 months of intervention;Measure Yourself Medical Outcome Profile v2 (MYMOP-2) questionnaireTimepoint: At baseline, after 1 month and 2 months of intervention	—

Countries

India

Contacts

Public ContactRajat Kumar Pal

D N De Homoeopathic Medical College and Hospital

drsujan4730@gmail.com8250384730

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026